AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Eon rockets past $1 billion valuation in under a year, raising tens of millions more
2
Monday.com founders: “We have everything needed to get to $10 billion in revenue”
3
Israel’s next tech boom: Pioneering the future of global defensetech
4
Wiz acquires Dazz for $450 million to strengthen AI-driven cloud security
5
Michael Levitt Analysis: Corona Is Slowing Down, Humanity Will Survive
More news

Can-Fite

5 stories about Can-Fite
גידול קנאביס סם סמים מריחואנה

Can-Fite’s Private Placement Could be Key to Avoiding a Hostile Takeover

11.09.19|Tzally Greenberg
NYSE and Tel Aviv-listed Israeli pharmaceutical company Can-Fite announced on Tuesday a collaboration agreement with Tel Aviv-listed medical cannabis cannabis company Univo, which will receive a 16.6% stake in the former
מגדל לוטה Lotte סיאול דרום קוריאה 2

Can-Fite BioPharma Signs South Korean Distribution Agreement for Psoriasis Treatment Drug

04.08.19|Adi Pick
The agreement, signed with pharma company Kyongbo Pharm, is contingent upon regulatory approval for the drug, currently in phase 3 clinical trials
רפואה בריאות רפואי תרופות מחקר

Can-Fite BioPharma Receives $1 Million From CKD Pharmaceuticals as Part of Expanded Agreement

16.04.19|CTech
Israel-based Can-Fite expanded its distribution agreement with the South Korean company in February, and is entitled to up to $5 million more in milestones
מוסף רפואה מבחנה מבחנות תרופה תרופות בית חולים

Can-Fite BioPharma to Raise $3.2 Million in Direct Offering

04.04.19|CTech
The NYSE and Tel Aviv-listed company develops small molecule drugs used in the treatment of liver and inflammatory diseases and cancer
מוסף רפואה מבחנה מבחנות תרופה תרופות בית חולים

China’s CMS Medical Signs Multi-Million Dollar Deal With Israeli Pharma Company Can-Fite

07.08.18|Amarelle Wenkert
New York-listed Can-Fite develops small molecule drugs used in the treatment of liver and inflammatory diseases and cancer